Gastrointestinal Conditions News

Prepackaged caramel apples produced by Happy Apple Company of Washington, Mo., have been linked to an ongoing outbreak of listeriosis, according to an FDA press release.

A new formulation of oral budesonide suspension was safe and effective for treatment of pediatric eosinophilic esophagitis, according to new research data.

Recent study data on pediatric gastrointestinal conditions have been abundant, particularly among presentations at the many gastroenterological society meetings this fall.

The CDC and FDA announced an ongoing investigation of an outbreak of listeria infections associated with commercially produced, prepackaged caramel apples.

Prucalopride was well tolerated in children with functional constipation but not more effective than placebo, according to new research data.

As the second leading cause of death worldwide among children aged younger than 5 years, gastroenteritis poses a serious burden, both globally and domestically.

ORLANDO, Fla. — Evidence supports partial enteral nutrition therapy and Crohn’s disease exclusion diet for treatment of pediatric Crohn’s disease, and these data can improve understanding of the link between diet, dysbiosis and pediatric IBD, according to a presenter at the Advances in IBD meeting.

New data suggest that a substantial number of Clostridium difficile infections may be missed if surveillance does not include outpatient settings or other nontraditional health care settings.

The FDA has issued a warning about the risks associated with the use of dietary supplements containing live bacteria or yeast among immunocompromised patients.

ORLANDO, Fla. — Two studies presented at the Advances in IBD meeting showed the potential neurological and psychological implications of treating pediatric Crohn’s disease, with these patients showing cortical thinning and more school problems than healthy counterparts.